DK1339737T3 - Immunomodulatorisk protein dannet ud fra Yaba-abetumorvirus - Google Patents
Immunomodulatorisk protein dannet ud fra Yaba-abetumorvirusInfo
- Publication number
- DK1339737T3 DK1339737T3 DK01999573T DK01999573T DK1339737T3 DK 1339737 T3 DK1339737 T3 DK 1339737T3 DK 01999573 T DK01999573 T DK 01999573T DK 01999573 T DK01999573 T DK 01999573T DK 1339737 T3 DK1339737 T3 DK 1339737T3
- Authority
- DK
- Denmark
- Prior art keywords
- tumor virus
- immunomodulatory protein
- protein formed
- yaba monkey
- monkey tumor
- Prior art date
Links
- 241001536558 Yaba monkey tumor virus Species 0.000 title abstract 2
- 230000002519 immonomodulatory effect Effects 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Obesity (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25114700P | 2000-12-04 | 2000-12-04 | |
| PCT/CA2001/001734 WO2002046214A2 (en) | 2000-12-04 | 2001-12-04 | Immunomodulatory protein derived from the yaba monkey tumor virus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1339737T3 true DK1339737T3 (da) | 2007-10-15 |
Family
ID=22950675
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK01999573T DK1339737T3 (da) | 2000-12-04 | 2001-12-04 | Immunomodulatorisk protein dannet ud fra Yaba-abetumorvirus |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7101559B2 (da) |
| EP (1) | EP1339737B1 (da) |
| JP (3) | JP4472252B2 (da) |
| AT (1) | ATE364625T1 (da) |
| AU (2) | AU1572702A (da) |
| CA (1) | CA2428097A1 (da) |
| DE (1) | DE60128950T2 (da) |
| DK (1) | DK1339737T3 (da) |
| ES (1) | ES2287192T3 (da) |
| PT (1) | PT1339737E (da) |
| WO (1) | WO2002046214A2 (da) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002211744B8 (en) | 2000-10-11 | 2008-03-20 | Viron Therapeutics, Inc. | Nucleic acid molecules and polypeptides for immune modulation |
| CA2428097A1 (en) | 2000-12-04 | 2002-06-13 | Viron Therapeutics, Inc. | Immunomodulatory protein derived from the yaba monkey tumor virus |
| US7718368B2 (en) | 2000-12-04 | 2010-05-18 | Viron Therapeutics Inc. | Immunomodulatory protein and useful embodiments thereof |
| US8251876B2 (en) | 2008-04-22 | 2012-08-28 | Hill-Rom Services, Inc. | Breathing exercise apparatus |
| US9180271B2 (en) | 2012-03-05 | 2015-11-10 | Hill-Rom Services Pte. Ltd. | Respiratory therapy device having standard and oscillatory PEP with nebulizer |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US38203A (en) * | 1863-04-14 | Improved strike for door-locks | ||
| US5651972A (en) * | 1989-04-21 | 1997-07-29 | University Of Florida Research Foundation, Inc. | Use of recombinant swine poxvirus as a live vaccine vector |
| ATE112312T1 (de) | 1990-04-24 | 1994-10-15 | Schering Corp | Lösliche verkürzte interferon-gamma rezeptoren. |
| DK0604418T3 (da) | 1991-03-29 | 1999-06-14 | Immunex Corp | Isolerede viralproteincytokinantagonister |
| PT754054E (pt) * | 1994-04-08 | 2002-10-31 | Viron Therapeutics Inc | Proteina anti-restenose |
| US5656465A (en) * | 1994-05-04 | 1997-08-12 | Therion Biologics Corporation | Methods of in vivo gene delivery |
| US5939525A (en) * | 1995-03-27 | 1999-08-17 | Viron Therapeutics, Inc. | Methods of treating inflammation and compositions therefor |
| AU718049B2 (en) | 1995-04-19 | 2000-04-06 | Viron Therapeutics, Inc. | Chemokine binding protein and methods of use therefor |
| US6495515B1 (en) * | 1995-04-19 | 2002-12-17 | Viron Therapeutics, Inc. | Chemokine binding protein and methods of use therefor |
| US5871740A (en) * | 1995-09-29 | 1999-02-16 | Immunex Corporation | Methods of using poxvirus p35 as a chemokine inhibitor and compositions therefore |
| ATE196091T1 (de) * | 1996-05-22 | 2000-09-15 | Univ Alberta | Typ-2 chemokine-bindende proteine und verfahren zu deren verwendung |
| EP1034789A1 (en) * | 1996-05-22 | 2000-09-13 | University Of Alberta | Type-2 chemokine binding proteins and methods of use therefor |
| BR9816013A (pt) * | 1998-09-01 | 2003-01-21 | Hayashibara Biochem Lab | Proteìna de ligação de interleucina-18 |
| US6589933B1 (en) * | 1999-04-02 | 2003-07-08 | Viron Therapeutics, Inc. | Myxoma chemokine binding protein |
| WO2001066138A2 (en) * | 2000-03-07 | 2001-09-13 | U.S. Army Medical Research Institute Of Infectious Diseases | Dna vaccines against poxviruses |
| AU2002211744B8 (en) * | 2000-10-11 | 2008-03-20 | Viron Therapeutics, Inc. | Nucleic acid molecules and polypeptides for immune modulation |
| CA2428097A1 (en) | 2000-12-04 | 2002-06-13 | Viron Therapeutics, Inc. | Immunomodulatory protein derived from the yaba monkey tumor virus |
-
2001
- 2001-12-04 CA CA002428097A patent/CA2428097A1/en not_active Abandoned
- 2001-12-04 AT AT01999573T patent/ATE364625T1/de active
- 2001-12-04 WO PCT/CA2001/001734 patent/WO2002046214A2/en active IP Right Grant
- 2001-12-04 EP EP01999573A patent/EP1339737B1/en not_active Expired - Lifetime
- 2001-12-04 AU AU1572702A patent/AU1572702A/xx active Pending
- 2001-12-04 DK DK01999573T patent/DK1339737T3/da active
- 2001-12-04 PT PT01999573T patent/PT1339737E/pt unknown
- 2001-12-04 ES ES01999573T patent/ES2287192T3/es not_active Expired - Lifetime
- 2001-12-04 JP JP2002547951A patent/JP4472252B2/ja not_active Expired - Fee Related
- 2001-12-04 AU AU2002215727A patent/AU2002215727B8/en not_active Ceased
- 2001-12-04 DE DE60128950T patent/DE60128950T2/de not_active Expired - Lifetime
-
2003
- 2003-06-04 US US10/455,000 patent/US7101559B2/en not_active Expired - Fee Related
-
2009
- 2009-05-26 JP JP2009126008A patent/JP2009227686A/ja not_active Withdrawn
- 2009-10-30 JP JP2009249633A patent/JP2010077136A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2002215727B9 (en) | 2008-02-21 |
| JP2010077136A (ja) | 2010-04-08 |
| WO2002046214A2 (en) | 2002-06-13 |
| JP2009227686A (ja) | 2009-10-08 |
| PT1339737E (pt) | 2007-09-03 |
| AU1572702A (en) | 2002-06-18 |
| AU2002215727B8 (en) | 2008-02-21 |
| DE60128950T2 (de) | 2008-02-28 |
| US20040038203A1 (en) | 2004-02-26 |
| WO2002046214A3 (en) | 2002-09-26 |
| DE60128950D1 (de) | 2007-07-26 |
| ATE364625T1 (de) | 2007-07-15 |
| AU2002215727B2 (en) | 2007-08-16 |
| ES2287192T3 (es) | 2007-12-16 |
| JP4472252B2 (ja) | 2010-06-02 |
| US7101559B2 (en) | 2006-09-05 |
| EP1339737B1 (en) | 2007-06-13 |
| CA2428097A1 (en) | 2002-06-13 |
| EP1339737A2 (en) | 2003-09-03 |
| JP2004522427A (ja) | 2004-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE540129T1 (de) | Target zur therapie kognitiver behinderungen | |
| ATE519862T1 (de) | Zusammensetzungen, kits und verfahren zur identifizierung, beurteilung, vorbeugung und therapie von gebärmutterhalskrebs | |
| DE69637047D1 (de) | Unabhängiges gerät zur extraktion, amplifikation und nachweis von nukleinsäuren | |
| WO2002101075A9 (en) | Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer | |
| WO2003004989A3 (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer | |
| BR0111125A (pt) | Moléculas de ácido nucléico de nrg-2, polipeptìdeos, e métodos diagnóstico e terapêuticos | |
| NO20034056D0 (no) | Proliferative sykdommer | |
| DE60035778D1 (de) | Rekombinante influenzaviren zur vakzinherstellung und gentherapie | |
| WO2002071928A3 (en) | Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer | |
| ATE369380T1 (de) | Impfstoff zur verhütung und behanldung von alzheimer-demenz und von amyloid-bezogenen krankheiten | |
| DE60137337D1 (de) | Vorbeugende und therapeutsche monoklonale antikörper gegen vacciniavirusantigene | |
| FR2824326B1 (fr) | Melange de peptides issus des proteines e6 et/ou e7 de papillomavirus et leurs applications | |
| AU6160201A (en) | Human polypeptides causing or leading to the killing of cells including lymphoidtumor cells | |
| DK1515752T3 (da) | ACE2-aktivering til behandling af hjerte-, lunge- og nyresygdomme og hypertension | |
| WO2004106495A3 (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer | |
| CY1114614T1 (el) | Αντιγονα αιμοφιλου ινφλουεντσας και αντιστοιχα dna θραυσματα | |
| CY1105331T1 (el) | Χιμαιρικα γονιδια που κωδικοποιουν τους αντιγονικους καθοριστες τεσσαρων πρωτεϊνων του l. infantum | |
| ATE285239T1 (de) | Dna enthaltende impfstoffen | |
| CY1109023T1 (el) | Gm-αρνητικα μεταλλαγματα ehv | |
| DK1339737T3 (da) | Immunomodulatorisk protein dannet ud fra Yaba-abetumorvirus | |
| DE60101224D1 (de) | Hydroxamsäure derivate | |
| DE60107888D1 (de) | Beta-Interferon zur Behandlung von Immunerkrankungen | |
| EA200200319A1 (ru) | Белок iren, его получение и использование | |
| HUP0103871A2 (hu) | Rekombináns CELO-vírus és CELO vírus DNS | |
| WO2007126788A3 (en) | Methods and compositions for the treatment and prevention of viral infection |